Ross L. Prentice - Publications

Affiliations: 
University of Washington, Seattle, Seattle, WA 
Area:
Biostatistics Biology

287 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Prentice RL, Pettinger M, Neuhouser ML, Raftery D, Zheng C, Gowda GAN, Huang Y, Tinker LF, Howard BV, Manson JAE, Wallace R, Mossavar-Rahmani Y, Johnson KC, Lampe JW. Four-day food record macronutrient intake, with and without biomarker calibration, and chronic disease risk in postmenopausal women. American Journal of Epidemiology. PMID 35094071 DOI: 10.1093/aje/kwac017  0.495
2022 Prentice RL, Pettinger M, Zheng C, Neuhouser ML, Raftery D, Gowda GAN, Huang Y, Tinker LF, Howard BV, Manson JE, Van Horn L, Wallace R, Mossavar-Rahmani Y, Johnson KC, Snetselaar L, et al. Biomarkers for Components of Dietary Protein and Carbohydrate with Application to Chronic Disease Risk Among Postmenopausal Women. The Journal of Nutrition. PMID 35015878 DOI: 10.1093/jn/nxac004  0.478
2021 Huang Y, Zheng C, Tinker LF, Neuhouser ML, Prentice RL. Biomarker-based Methods and Study Designs to Calibrate Dietary Intake for Assessing Diet-Disease Associations. The Journal of Nutrition. PMID 34905061 DOI: 10.1093/jn/nxab420  0.445
2021 Zheng C, Gowda GAN, Raftery D, Neuhouser ML, Tinker LF, Prentice RL, Beresford SAA, Zhang Y, Bettcher L, Pepin R, Djukovic D, Gu H, Barding GA, Song X, Lampe JW. Evaluation of potential metabolomic-based biomarkers of protein, carbohydrate and fat intakes using a controlled feeding study. European Journal of Nutrition. PMID 33991228 DOI: 10.1007/s00394-021-02577-1  0.435
2021 Prentice RL, Pettinger M, Neuhouser ML, Raftery D, Zheng C, Gowda GAN, Huang Y, Tinker LF, Howard BV, Manson JE, Wallace R, Mossavar-Rahmani Y, Johnson KC, Lampe JW. Biomarker-Calibrated Macronutrient Intake and Chronic Disease Risk among Postmenopausal Women. The Journal of Nutrition. PMID 33880504 DOI: 10.1093/jn/nxab091  0.466
2021 Prentice RL, Howard BV, Van Horn L, Neuhouser ML, Anderson GL, Tinker LF, Lampe JW, Raftery D, Pettinger M, Aragaki AK, Thomson CA, Mossavar-Rahmani Y, Stefanick ML, Cauley JA, Rossouw JE, et al. Nutritional epidemiology and the Women's Health Initiative: a review. The American Journal of Clinical Nutrition. PMID 33876183 DOI: 10.1093/ajcn/nqab091  0.312
2021 Huyghe JR, Harrison TA, Bien SA, Hampel H, Figueiredo JC, Schmit SL, Conti DV, Chen S, Qu C, Lin Y, Barfield R, Baron JA, Cross AJ, Diergaarde B, Duggan D, ... ... Prentice RL, et al. Genetic architectures of proximal and distal colorectal cancer are partly distinct. Gut. PMID 33632709 DOI: 10.1136/gutjnl-2020-321534  0.442
2020 Prentice RL, Zhao S. Regression Models and Multivariate Life Tables. Journal of the American Statistical Association. 116: 1330-1345. PMID 34629570 DOI: 10.1080/01621459.2020.1713792  0.469
2020 Prentice RL, Zhao S. Regression Models and Multivariate Life Tables. Journal of the American Statistical Association. 116: 1330-1345. PMID 34629570 DOI: 10.1080/01621459.2020.1713792  0.469
2020 Prentice RL, Aragaki AK, Chlebowski RT, Rossouw JE, Anderson GL, Stefanick ML, Wactawski-Wende J, Kuller LH, Wallace R, Johnson KC, Shadyab AH, Gass M, Manson JAE. Randomized Trial Evaluation of Benefits and Risks of Menopausal Hormone Therapy Among Women Aged 50-59. American Journal of Epidemiology. PMID 33025002 DOI: 10.1093/aje/kwaa210  0.33
2020 Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick ML, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, ... ... Prentice RL, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women's Health Initiative Randomized Clinical Trials. Jama. 324: 369-380. PMID 32721007 DOI: 10.1001/Jama.2020.9482  0.387
2020 Yun HY, Tinker LF, Neuhouser ML, Schoeller DA, Mossavar-Rahmani Y, Snetselaar LG, Van Horn LV, Eaton CB, Prentice RL, Lampe JW, O'Brien DM. The Carbon Isotope Ratios of Serum Amino Acids in Combination with Participant Characteristics can be Used to Estimate Added Sugar Intake in a Controlled Feeding Study of US Postmenopausal Women. The Journal of Nutrition. PMID 32712658 DOI: 10.1093/Jn/Nxaa195  0.305
2020 Chlebowski RT, Aragaki AK, Prentice RL. Dietary Moderation and Deaths From Breast Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2001218. PMID 32614701 DOI: 10.1200/Jco.20.01218  0.339
2020 Prentice RL, Aragaki AK, Chlebowski RT, Zhao S, Anderson GL, Rossouw JE, Wallace R, Banack H, Shadyab AH, Qi L, Snively BM, Gass M, Manson JAE. Response to Commentary on 'Dual Outcome Intention-To-Treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials'. American Journal of Epidemiology. PMID 32314786 DOI: 10.1093/Aje/Kwaa032  0.63
2020 Prentice RL, Aragaki AK, Chlebowski RT, Zhao S, Anderson GL, Rossouw JE, Wallace R, Banack H, Shadyab AH, Qi L, Snively BM, Gass M, Manson JAE. Dual Outcome Intention-to-treat Analyses in the Women's Health Initiative Randomized Controlled Hormone Therapy Trials. American Journal of Epidemiology. PMID 32314781 DOI: 10.1093/Aje/Kwaa033  0.641
2020 Chlebowski RT, Aragaki AK, Anderson GL, Prentice RL. Forty-year trends in menopausal hormone therapy use and breast cancer incidence among postmenopausal black and white women. Cancer. PMID 32212335 DOI: 10.1002/Cncr.32846  0.382
2020 Prentice RL, Pettinger M, Neuhouser ML, Tinker LF, Huang Y, Zheng C, Manson JE, Mossavar-Rahmani Y, Anderson GL, Lampe JW. Can dietary self-reports usefully complement blood concentrations for estimation of micronutrient intake and chronic disease associations? The American Journal of Clinical Nutrition. PMID 32133498 DOI: 10.1093/Ajcn/Nqaa034  0.558
2020 Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, Thomson CA, Mossavar-Rahmani Y, Lane DS, Johnson KC, Wactawski-Wende J, Snetselaar L, Rohan TE, Luo J, Barac A, ... Prentice RL, et al. Dietary Modification and Breast Cancer Mortality: Long-Term Follow-Up of the Women's Health Initiative Randomized Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO1900435. PMID 32031879 DOI: 10.1200/Jco.19.00435  0.414
2020 Escala-Garcia M, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Ashworth A, Auer PL, Auvinen P, Beckmann MW, Beesley J, Behrens S, Benitez J, Bermisheva M, Blomqvist C, Blot W, ... ... Prentice RL, et al. A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications. 11: 312. PMID 31949161 DOI: 10.1038/S41467-019-14100-6  0.337
2020 Chlebowski RT, Rapp S, Aragaki AK, Pan K, Neuhouser ML, Snetselaar LG, Manson JE, Wactawski-Wende J, Johnson KC, Hayden K, Baker LD, Henderson VW, Garcia L, Qi L, Prentice RL. Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial. Eclinicalmedicine. 18: 100240. PMID 31938786 DOI: 10.1016/J.Eclinm.2019.100240  0.469
2020 Chlebowski RT, Anderson GL, Aragaki AK, Manson JE, Stefanick M, Pan K, Barrington W, Kuller LH, Simon MS, Lane D, Johnson KC, Rohan TE, Gass MLS, Cauley JA, Paskett ED, ... ... Prentice RL, et al. Abstract GS5-00: Long-term influence of estrogen plus progestin and estrogen alone use on breast cancer incidence: The Women's Health Initiative randomized trials Cancer Research. 80. DOI: 10.1158/1538-7445.Sabcs19-Gs5-00  0.401
2019 Manson JE, Aragaki AK, Bassuk SS, Chlebowski RT, Anderson GL, Rossouw JE, Howard BV, Thomson CA, Stefanick ML, Kaunitz AM, Crandall CJ, Eaton CB, Henderson VW, Liu S, Luo J, ... ... Prentice RL, et al. Menopausal Estrogen-Alone Therapy and Health Outcomes in Women With and Without Bilateral Oophorectomy: A Randomized Trial. Annals of Internal Medicine. PMID 31499528 DOI: 10.7326/M19-0274  0.322
2019 Huang JY, Larose TL, Luu HN, Wang R, Fanidi A, Alcala K, Stevens VL, Weinstein SJ, Albanes D, Caporaso NE, Purdue MP, Ziegler RG, Freedman ND, Lan Q, Prentice RL, et al. Circulating markers of cellular immune activation in pre-diagnostic blood sample and lung cancer risk in the Lung Cancer Cohort Consortium (LC3). International Journal of Cancer. PMID 31276202 DOI: 10.1002/Ijc.32555  0.307
2019 Prentice RL, Aragaki AK, Howard BV, Chlebowski RT, Thomson CA, Van Horn L, Tinker LF, Manson JE, Anderson GL, Kuller LE, Neuhouser ML, Johnson KC, Snetselaar L, Rossouw JE. Low-Fat Dietary Pattern among Postmenopausal Women Influences Long-Term Cancer, Cardiovascular Disease, and Diabetes Outcomes. The Journal of Nutrition. PMID 31175807 DOI: 10.1093/Jn/Nxz107  0.352
2019 Prentice RL, Pettinger M, Neuhouser ML, Tinker LF, Huang Y, Zheng C, Manson JE, Mossavar-Rahmani Y, Anderson GL, Lampe JW. Application of blood concentration biomarkers in nutritional epidemiology: example of carotenoid and tocopherol intake in relation to chronic disease risk. The American Journal of Clinical Nutrition. PMID 30915444 DOI: 10.1093/Ajcn/Nqy360  0.51
2019 Escala-Garcia M, Guo Q, Dörk T, Canisius S, Keeman R, Dennis J, Beesley J, Lecarpentier J, Bolla MK, Wang Q, Abraham J, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, ... ... Prentice R, et al. Genome-wide association study of germline variants and breast cancer-specific mortality. British Journal of Cancer. PMID 30787463 DOI: 10.1038/S41416-019-0393-X  0.359
2019 Zuo H, Ueland PM, Midttun Ø, Tell GS, Fanidi A, Zheng W, Shu X, Xiang Y, Wu J, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, et al. Vitamin B6 catabolism and lung cancer risk: results from the Lung Cancer Cohort Consortium (LC3). Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 30698666 DOI: 10.1093/Annonc/Mdz002  0.313
2019 Chlebowski RT, Aragaki AK, Anderson GL, Pan K, Neuhouser ML, Manson JE, Thomson CA, Mossavar-Rahmani Y, Lane D, Johnson K, Wactawski-Wende J, Linda S, Rohan TE, Luo J, Barac A, ... Prentice RL, et al. Low-fat dietary pattern and long-term breast cancer incidence and mortality: The Women’s Health Initiative randomized clinical trial. Journal of Clinical Oncology. 37: 520-520. DOI: 10.1200/Jco.2019.37.15_Suppl.520  0.399
2019 Chlebowski RT, Aragaki AK, Anderson GL, Prentice RL. Abstract LB-170: Breast cancer incidence and hormone therapy use before and after the Women’s Health Initiative (WHI) estrogen (E) plus progestin (P) trial by race/ethnicity Cancer Research. 79. DOI: 10.1158/1538-7445.Am2019-Lb-170  0.39
2018 Chlebowski RT, Anderson GL, Manson JE, Prentice RL, Aragaki AK, Snetselaar L, Beresford SAA, Kuller LH, Johnson K, Lane D, Luo J, Rohan TE, Jiao L, Barac A, Womack C, et al. Low-Fat Dietary Pattern and Cancer Mortality in the Women's Health Initiative (WHI) Randomized Controlled Trial. Jnci Cancer Spectrum. 2: pky065. PMID 31360880 DOI: 10.1093/Jncics/Pky065  0.396
2018 Mavaddat N, Michailidou K, Dennis J, Lush M, Fachal L, Lee A, Tyrer JP, Chen TH, Wang Q, Bolla MK, Yang X, Adank MA, Ahearn T, Aittomäki K, Allen J, ... ... Prentice R, et al. Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. American Journal of Human Genetics. PMID 30554720 DOI: 10.1016/J.Ajhg.2018.11.002  0.398
2018 Li K, Anderson G, Viallon V, Arveux P, Kvaskoff M, Fournier A, Krogh V, Tumino R, Sánchez MJ, Ardanaz E, Chirlaque MD, Agudo A, Muller DC, Smith T, Tzoulaki I, ... ... Prentice R, et al. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts. Breast Cancer Research : Bcr. 20: 147. PMID 30509329 DOI: 10.1186/S13058-018-1073-0  0.335
2018 Fanidi A, Carreras-Torres R, Larose TL, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Pettinger M, Cai Q, Blot WJ, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, Le Marchand L, et al. Is high vitamin B12 status a cause of lung cancer? International Journal of Cancer. PMID 30499135 DOI: 10.1002/Ijc.32033  0.319
2018 Yun HY, Lampe JW, Tinker LF, Neuhouser ML, Beresford SAA, Niles KR, Mossavar-Rahmani Y, Snetselaar LG, Van Horn L, Prentice RL, O'Brien DM. Serum Nitrogen and Carbon Stable Isotope Ratios Meet Biomarker Criteria for Fish and Animal Protein Intake in a Controlled Feeding Study of a Women's Health Initiative Cohort. The Journal of Nutrition. PMID 30239866 DOI: 10.1093/Jn/Nxy168  0.316
2018 Freedman LS, Midthune D, Arab L, Prentice RL, Subar AF, Willett W, Neuhouser ML, Tinker LF, Kipnis V. Combining a Food Frequency Questionnaire With 24-Hour Recalls to Increase the Precision of Estimating Usual Dietary Intakes - Evidence From the Validation Studies Pooling Project. American Journal of Epidemiology. PMID 29917051 DOI: 10.1093/Aje/Kwy126  0.343
2018 Wu L, Shi W, Long J, Guo X, Michailidou K, Beesley J, Bolla MK, Shu XO, Lu Y, Cai Q, Al-Ejeh F, Rozali E, Wang Q, Dennis J, Li B, ... ... Prentice R, et al. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer. Nature Genetics. PMID 29915430 DOI: 10.1038/S41588-018-0132-X  0.357
2018 Tasevska N, Pettinger M, Kipnis V, Midthune D, Tinker LF, Potischman N, Neuhouser ML, Beasley JM, Van Horn L, Howard BV, Liu S, Manson JE, Shikany JM, Thomson CA, Prentice RL. Biomarker-Calibrated Total Sugars Intake and Risk of Type 2 Diabetes and Cardiovascular Disease in the Women's Health Initiative Observational Study. American Journal of Epidemiology. PMID 29868784 DOI: 10.1093/Aje/Kwy115  0.39
2018 Chlebowski RT, Aragaki AK, Anderson GL, Simon MS, Manson JE, Neuhouser ML, Pan K, Stefanic ML, Rohan TE, Lane D, Qi L, Snetselaar L, Prentice RL. Association of Low-Fat Dietary Pattern With Breast Cancer Overall Survival: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trial. Jama Oncology. e181212. PMID 29800122 DOI: 10.1001/Jamaoncol.2018.1212  0.589
2018 Shufelt C, Bairey Merz CN, Pettinger MB, Choi L, Chlebowski R, Crandall CJ, Liu S, Lane D, Prentice R, Manson JE. Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study. Menopause (New York, N.Y.). PMID 29738414 DOI: 10.1097/Gme.0000000000001115  0.338
2018 Fanidi A, Muller DC, Yuan JM, Stevens VL, Weinstein SJ, Albanes D, Prentice R, Thomsen CA, Pettinger M, Cai Q, Blot WJ, Wu J, Arslan AA, Zeleniuch-Jacquotte A, McCullough ML, et al. Circulating Folate, Vitamin B6, and Methionine in Relation to Lung Cancer Risk in the Lung Cancer Cohort Consortium (LC3). Journal of the National Cancer Institute. 110. PMID 28922778 DOI: 10.1093/Jnci/Djx119  0.32
2018 Chlebowski RT, Anderson GL, Manson JE, Prentice RL, Aragaki AK, Linda S, Beresford SA, Kuller LH, Johnson K, Lane D, Luo J, Rohan TE, Jiao L, Barac A, Womack C, et al. Low-fat dietary pattern and all cancer mortality in the Women's Health Initiative (WHI) randomized trial. Journal of Clinical Oncology. 36: 1500-1500. DOI: 10.1200/Jco.2018.36.15_Suppl.1500  0.401
2017 Howard BV, Aragaki AK, Tinker LF, Allison M, Hingle MD, Johnson KC, Manson JE, Shadyab AH, Shikany JM, Snetselaar LG, Thomson CA, Zaslavsky O, Prentice RL. A Low-Fat Dietary Pattern and Diabetes: A Secondary Analysis From the Women's Health Initiative Dietary Modification Trial. Diabetes Care. PMID 29282203 DOI: 10.2337/Dc17-0534  0.32
2017 Mahabir S, Willett WC, Friedenreich CM, Lai GY, Boushey CJ, Matthews CE, Sinha R, Colditz GA, Rothwell JA, Reedy J, Patel AV, Leitzmann MF, Fraser GE, Ross S, Hursting SD, ... ... Prentice R, et al. Research Strategies for Nutritional and Physical Activity Epidemiology and Cancer Prevention. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29254934 DOI: 10.1158/1055-9965.Epi-17-0509  0.323
2017 Theofylaktopoulou D, Midttun Ø, Ueland PM, Meyer K, Fanidi A, Zheng W, Shu XO, Xiang YB, Prentice R, Pettinger M, Thomson CA, Giles GG, Hodge A, Cai Q, Blot WJ, et al. Impaired functional vitamin B6 status is associated with increased risk of lung cancer. International Journal of Cancer. PMID 29238985 DOI: 10.1002/Ijc.31215  0.337
2017 Bock CH, Jay AM, Dyson G, Beebe-Dimmer JL, Cote ML, Hou L, Howard BV, Desai P, Purrington K, Prentice R, Simon MS. The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Research and Treatment. PMID 29063981 DOI: 10.1007/S10549-017-4521-0  0.391
2017 Michailidou K, Lindström S, Dennis J, Beesley J, Hui S, Kar S, Lemaçon A, Soucy P, Glubb D, Rostamianfar A, Bolla MK, Wang Q, Tyrer J, Dicks E, Lee A, ... ... Prentice R, et al. Association analysis identifies 65 new breast cancer risk loci. Nature. PMID 29059683 DOI: 10.1038/Nature24284  0.357
2017 Milne RL, Kuchenbaecker KB, Michailidou K, Beesley J, Kar S, Lindström S, Hui S, Lemaçon A, Soucy P, Dennis J, Jiang X, Rostamianfar A, Finucane H, Bolla MK, McGuffog L, ... ... Prentice R, et al. Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer. Nature Genetics. PMID 29058716 DOI: 10.1038/Ng.3785  0.359
2017 Dai JY, Liang CJ, LeBlanc M, Prentice RL, Janes H. Case-only approach to identifying markers predicting treatment effects on the relative risk scale. Biometrics. PMID 28960244 DOI: 10.1111/Biom.12789  0.343
2017 Manson JE, Aragaki AK, Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Chlebowski RT, Howard BV, Thomson CA, Margolis KL, Lewis CE, Stefanick ML, Jackson RD, Johnson KC, Martin LW, et al. Menopausal Hormone Therapy and Long-term All-Cause and Cause-Specific Mortality: The Women's Health Initiative Randomized Trials. Jama. 318: 927-938. PMID 28898378 DOI: 10.1001/jama.2017.11217  0.333
2017 Cespedes Feliciano EM, Prentice RL, Aragaki AK, Neuhouser ML, Banack HR, Kroenke CH, Ho GYF, Zaslavsky O, Strickler HD, Cheng TD, Chlebowski RT, Saquib N, Nassir R, Anderson G, Caan BJ. Methodological Considerations for Disentangling a Risk Factor's Influence on Disease Incidence versus Post-Diagnosis Survival: The Example of Obesity and Breast and Colorectal Cancer Mortality in the Women's Health Initiative. International Journal of Cancer. PMID 28833074 DOI: 10.1002/Ijc.30931  0.392
2017 Isanejad M, LaCroix AZ, Thomson CA, Tinker L, Larson JC, Qi Q, Qi L, Cooper-DeHoff RM, Phillips LS, Prentice RL, Beasley JM. Branched-chain amino acid, meat intake and risk of type 2 diabetes in the Women's Health Initiative. The British Journal of Nutrition. 117: 1523-1530. PMID 28721839 DOI: 10.1017/S0007114517001568  0.562
2017 Crandall CJ, Hovey KM, Andrews C, Cauley JA, Stefanick M, Shufelt C, Prentice RL, Kaunitz AM, Eaton C, Wactawski-Wende J, Manson JE. Comparison of clinical outcomes among users of oral and transdermal estrogen therapy in the Women's Health Initiative Observational Study. Menopause (New York, N.Y.). PMID 28697036 DOI: 10.1097/Gme.0000000000000899  0.339
2017 Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, Manson JE, Simon MS, Howard BV, Rohan TE, Snetselar L, Lane D, Barrington W, Vitolins MZ, Womack C, Qi L, Hou L, ... ... Prentice RL, et al. Low-Fat Dietary Pattern and Breast Cancer Mortality in the Women's Health Initiative Randomized Controlled Trial. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016720326. PMID 28654363 DOI: 10.1200/Jco.2016.72.0326  0.581
2017 Prentice RL, Huang Y, Neuhouser ML, Tinker LF, Van Horn L. Response to Invitation to Submit a Reply to CommentaryAJE-00463-2017 - Can estimation of sodium intake be improved by borrowing information from other variables?Tied to: AJE-00876-2016.R4 - BIOMARKER CALIBRATED SODIUM AND POTASSIUM INTAKE AND CARDIOVASCULAR DISEASE RISK AMONG POSTMENOPAUSAL WOMEN. American Journal of Epidemiology. PMID 28633415 DOI: 10.1093/Aje/Kwx237  0.36
2017 Prentice RL, Huang Y, Neuhouser ML, Manson JE, Mossavar-Rahmani Y, Thomas F, Tinker LF, Allison M, Johnson KC, Wassertheil-Smoller S, Seth A, Rossouw JE, Shikany J, Carbone LD, Martin LW, et al. BIOMARKER CALIBRATED SODIUM AND POTASSIUM INTAKE AND CARDIOVASCULAR DISEASE RISK AMONG POSTMENOPAUSAL WOMEN. American Journal of Epidemiology. PMID 28633342 DOI: 10.1093/Aje/Kwx238  0.351
2017 Prentice RL, Aragaki AK, Van Horn L, Thomson CA, Beresford SA, Robinson J, Snetselaar L, Anderson GL, Manson JE, Allison MA, Rossouw JE, Howard BV. Low-fat dietary pattern and cardiovascular disease: results from the Women's Health Initiative randomized controlled trial. The American Journal of Clinical Nutrition. PMID 28515068 DOI: 10.3945/Ajcn.117.153270  0.389
2017 Song X, Huang Y, Neuhouser ML, Tinker LF, Vitolins MZ, Prentice RL, Lampe JW. Dietary long-chain fatty acids and carbohydrate biomarker evaluation in a controlled feeding study in participants from the Women's Health Initiative cohort. The American Journal of Clinical Nutrition. PMID 28446501 DOI: 10.3945/Ajcn.117.153072  0.336
2017 Freedman LS, Commins JM, Willett W, Tinker LF, Spiegelman D, Rhodes D, Potischman N, Neuhouser ML, Moshfegh AJ, Kipnis V, Baer DJ, Arab L, Prentice RL, Subar AF. Evaluation of the 24-Hour Recall as a Reference Instrument for Calibrating Other Self-Report Instruments in Nutritional Cohort Studies: Evidence From the Validation Studies Pooling Project. American Journal of Epidemiology. 1-10. PMID 28402488 DOI: 10.1093/Aje/Kwx039  0.362
2016 Lampe JW, Huang Y, Neuhouser ML, Tinker LF, Song X, Schoeller DA, Kim S, Raftery D, Di C, Zheng C, Schwarz Y, Van Horn L, Thomson CA, Mossavar-Rahmani Y, Beresford SA, ... Prentice RL, et al. Dietary biomarker evaluation in a controlled feeding study in women from the Women's Health Initiative cohort. The American Journal of Clinical Nutrition. PMID 28031191 DOI: 10.3945/Ajcn.116.144840  0.532
2016 Chlebowski RT, Barrington W, Aragaki AK, Manson JE, Sarto G, OʼSullivan MJ, Wu D, Cauley JA, Qi L, Wallace RL, Prentice RL. Estrogen alone and health outcomes in black women by African ancestry: a secondary analyses of a randomized controlled trial. Menopause (New York, N.Y.). PMID 27749739 DOI: 10.1097/Gme.0000000000000733  0.56
2016 Prentice RL, Zhao S. Nonparametric estimation of the multivariate survivor function: the multivariate Kaplan-Meier estimator. Lifetime Data Analysis. PMID 27677472 DOI: 10.1007/S10985-016-9383-Y  0.518
2016 Arnold M, Jiang L, Stefanick ML, Johnson KC, Lane DS, LeBlanc ES, Prentice R, Rohan TE, Snively BM, Vitolins M, Zaslavsky O, Soerjomataram I, Anton-Culver H. Duration of Adulthood Overweight, Obesity, and Cancer Risk in the Women's Health Initiative: A Longitudinal Study from the United States. Plos Medicine. 13: e1002081. PMID 27529652 DOI: 10.1371/Journal.Pmed.1002081  0.333
2016 Maas P, Barrdahl M, Joshi AD, Auer PL, Gaudet MM, Milne RL, Schumacher FR, Anderson WF, Check D, Chattopadhyay S, Baglietto L, Berg CD, Chanock SJ, Cox DG, Figueroa JD, ... ... Prentice RL, et al. Breast Cancer Risk From Modifiable and Nonmodifiable Risk Factors Among White Women in the United States. Jama Oncology. PMID 27228256 DOI: 10.1001/Jamaoncol.2016.1025  0.38
2016 Fehringer G, Kraft P, Pharoah PD, Eeles RA, Chatterjee N, Schumacher FR, Schildkraut JM, Lindstrom S, Brennan P, Bickeböller H, Houlston RS, Landi MT, Caporaso NE, Risch A, Amin Al Olama A, ... ... Prentice RL, et al. Cross-cancer genome-wide analysis of lung, ovary, breast, prostate and colorectal cancer reveals novel pleiotropic associations. Cancer Research. PMID 27197191 DOI: 10.1158/0008-5472.Can-15-2980  0.333
2016 Carbone L, Johnson KC, Huang Y, Pettinger M, Thomas F, Cauley J, Crandall C, Tinker L, Susan LeBoff M, Wactawski-Wende J, Bethel M, Li W, Prentice R. Sodium Intake and Osteoporosis. Findings from the Women's Health Initiative. The Journal of Clinical Endocrinology and Metabolism. jc20154017. PMID 26863423 DOI: 10.1210/Jc.2015-4017  0.348
2016 Gaudet MM, Barrdahl M, Lindström S, Travis RC, Auer PL, Buring JE, Chanock SJ, Heather Eliassen A, Gapstur SM, Giles GG, Gunter M, Haiman C, Hunter DJ, Joshi AD, Kaaks R, ... ... Prentice RL, et al. Interactions between breast cancer susceptibility loci and menopausal hormone therapy in relationship to breast cancer in the Breast and Prostate Cancer Cohort Consortium. Breast Cancer Research and Treatment. PMID 26802016 DOI: 10.1007/S10549-016-3681-7  0.378
2016 Chlebowski RT, Aragaki AK, Anderson GL, Thomson CA, Manson JE, Simon MS, Howard BV, Rohan TE, Snetselaar L, Lane D, Barrington WE, Vitolilns MZ, Womack C, Qi L, Hou L, ... ... Prentice RL, et al. Abstract CT043: Low-fat dietary pattern and breast cancer mortality in the Women's Health Initiative (WHI) randomized trial Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Ct043  0.582
2015 Zhao S, Prentice RL. Rejoinder to "On the Misuse of Taylor Expansion". Biometrics. 71: 1195. PMID 26769150 DOI: 10.1111/Biom.12426  0.407
2015 Freedman LS, Midthune D, Carroll RJ, Commins JM, Arab L, Baer DJ, Moler JE, Moshfegh AJ, Neuhouser ML, Prentice RL, Rhodes D, Spiegelman D, Subar AF, Tinker LF, Willett W, et al. Application of a New Statistical Model for Measurement Error to the Evaluation of Dietary Self-report Instruments. Epidemiology (Cambridge, Mass.). 26: 925-33. PMID 26360372 DOI: 10.1097/Ede.0000000000000377  0.359
2015 Neuhouser ML, Aragaki AK, Prentice RL, Manson JE, Chlebowski R, Carty CL, Ochs-Balcom HM, Thomson CA, Caan BJ, Tinker LF, Urrutia RP, Knudtson J, Anderson GL. Overweight, Obesity, and Postmenopausal Invasive Breast Cancer Risk: A Secondary Analysis of the Women's Health Initiative Randomized Clinical Trials. Jama Oncology. 1: 611-21. PMID 26182172 DOI: 10.1001/Jamaoncol.2015.1546  0.375
2015 Chlebowski RT, Rohan TE, Manson JE, Aragaki AK, Kaunitz A, Stefanick ML, Simon MS, Johnson KC, Wactawski-Wende J, O'Sullivan MJ, Adams-Campbell LL, Nassir R, Lessin LS, Prentice RL. Breast Cancer After Use of Estrogen Plus Progestin and Estrogen Alone: Analyses of Data From 2 Women's Health Initiative Randomized Clinical Trials. Jama Oncology. 1: 296-305. PMID 26181174 DOI: 10.1001/Jamaoncol.2015.0494  0.372
2015 Freedman LS, Carroll RJ, Neuhouser ML, Prentice RL, Spiegelman D, Subar AF, Tinker LF, Willett W. Reply to E Archer and SN Blair. Advances in Nutrition (Bethesda, Md.). 6: 489. PMID 26178033 DOI: 10.3945/An.115.009118  0.301
2015 Katayama H, Boldt C, Ladd JJ, Johnson MM, Chao T, Capello M, Suo J, Mao J, Manson JE, Prentice R, Esteva F, Wang H, Disis ML, Hanash S. An autoimmune response signature associated with the development of triple negative breast cancer reflects disease pathogenesis. Cancer Research. PMID 26088128 DOI: 10.1158/0008-5472.Can-15-0248  0.346
2015 Lavasani S, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson KC, Young A, Rodabough R, Hubbell FA, Mahinbakht A, Simon MS. Estrogen and colorectal cancer incidence and mortality. Cancer. PMID 26036212 DOI: 10.1002/Cncr.29464  0.367
2015 Mossavar-Rahmani Y, Shaw PA, Wong WW, Sotres-Alvarez D, Gellman MD, Van Horn L, Stoutenberg M, Daviglus ML, Wylie-Rosett J, Siega-Riz AM, Ou FS, Prentice RL. Applying Recovery Biomarkers to Calibrate Self-Report Measures of Energy and Protein in the Hispanic Community Health Study/Study of Latinos. American Journal of Epidemiology. 181: 996-1007. PMID 25995289 DOI: 10.1093/Aje/Kwu468  0.504
2015 Chlebowski RT, Anderson GL, Prentice RL, Rossouw JE, Aragaki AK, Manson JE. Reliable evidence from placebo-controlled, randomized, clinical trials for menopausal hormone therapy's influence on incidence and deaths from breast cancer. Climacteric : the Journal of the International Menopause Society. 18: 336-8. PMID 25966858 DOI: 10.3109/13697137.2015.1038770  0.386
2015 Zhao S, Zheng Y, Prentice RL, Feng Z. Two-stage biomarker panel study and estimation allowing early termination for futility. Biostatistics (Oxford, England). 16: 799-812. PMID 25964662 DOI: 10.1093/Biostatistics/Kxv017  0.524
2015 Yang S, Prentice RL. Assessing potentially time-dependent treatment effect from clinical trials and observational studies for survival data, with applications to the Women's Health Initiative combined hormone therapy trial. Statistics in Medicine. 34: 1801-17. PMID 25689356 DOI: 10.1002/Sim.6453  0.365
2015 Baik CS, Brasky TM, Pettinger M, Luo J, Gong Z, Wactawski-Wende J, Prentice RL. Nonsteroidal Anti-Inflammatory Drug and Aspirin Use in Relation to Lung Cancer Risk among Postmenopausal Women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 790-7. PMID 25670808 DOI: 10.1158/1055-9965.Epi-14-1322  0.304
2015 Potter JD, Prentice RL. Cancer risk: tumors excluded. Science (New York, N.Y.). 347: 727. PMID 25656658 DOI: 10.1126/Science.Aaa6507  0.33
2015 Lewis JR, Radavelli-Bagatini S, Rejnmark L, Chen JS, Simpson JM, Lappe JM, Mosekilde L, Prentice RL, Prince RL. The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 30: 165-75. PMID 25042841 DOI: 10.1002/Jbmr.2311  0.344
2015 Chlebowski RT, Barrington W, Aragaki AK, Manson JE, Sarto G, O'Sullivan MJ, Cauley JA, Qi L, Wallace RB, Prentice RL. Estrogen alone and health outcomes in black women by African ancestry. Journal of Clinical Oncology. 33: 1502-1502. DOI: 10.1200/Jco.2015.33.15_Suppl.1502  0.579
2015 Fanidi A, Muller DC, Prentice R, Demetrius A, Yuan J, Stevens V, Weinstein SJ, Johansson M, Brennan P. Abstract 933: Circulating biomarkers of B vitamins in relation to lung cancer risk in the Lung Cancer Cohort Consortium Cancer Research. 75: 933-933. DOI: 10.1158/1538-7445.Am2015-933  0.348
2014 Prentice RL. Postmenopausal hormone therapy and the risks of coronary heart disease, breast cancer, and stroke. Seminars in Reproductive Medicine. 32: 419-25. PMID 25321418 DOI: 10.1055/S-0034-1384624  0.388
2014 Thomson CA, Van Horn L, Caan BJ, Aragaki AK, Chlebowski RT, Manson JE, Rohan TE, Tinker LF, Kuller LH, Hou L, Lane DS, Johnson KC, Vitolins MZ, Prentice RL. Cancer incidence and mortality during the intervention and postintervention periods of the Women's Health Initiative dietary modification trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2924-35. PMID 25258014 DOI: 10.1158/1055-9965.Epi-14-0922  0.415
2014 Tasevska N, Midthune D, Tinker LF, Potischman N, Lampe JW, Neuhouser ML, Beasley JM, Van Horn L, Prentice RL, Kipnis V. Use of a urinary sugars biomarker to assess measurement error in self-reported sugars intake in the nutrition and physical activity assessment study (NPAAS). Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 2874-83. PMID 25234237 DOI: 10.1158/1055-9965.Epi-14-0594  0.315
2014 Seth A, Mossavar-Rahmani Y, Kamensky V, Silver B, Lakshminarayan K, Prentice R, Van Horn L, Wassertheil-Smoller S. Potassium intake and risk of stroke in women with hypertension and nonhypertension in the Women's Health Initiative. Stroke; a Journal of Cerebral Circulation. 45: 2874-80. PMID 25190445 DOI: 10.1161/Strokeaha.114.006046  0.319
2014 Zhao S, Prentice RL. Covariate measurement error correction methods in mediation analysis with failure time data. Biometrics. 70: 835-44. PMID 25139469 DOI: 10.1111/Biom.12205  0.536
2014 Liu D, Zheng Y, Prentice RL, Hsu L. Estimating Risk with Time-to-Event Data: An Application to the Women's Health Initiative. Journal of the American Statistical Association. 109: 514-524. PMID 25018574 DOI: 10.1080/01621459.2014.881739  0.395
2014 Zheng C, Beresford SA, Van Horn L, Tinker LF, Thomson CA, Neuhouser ML, Di C, Manson JE, Mossavar-Rahmani Y, Seguin R, Manini T, LaCroix AZ, Prentice RL. Simultaneous association of total energy consumption and activity-related energy expenditure with risks of cardiovascular disease, cancer, and diabetes among postmenopausal women. American Journal of Epidemiology. 180: 526-35. PMID 25016533 DOI: 10.1093/Aje/Kwu152  0.573
2014 Barrdahl M, Canzian F, Joshi AD, Travis RC, Chang-Claude J, Auer PL, Gapstur SM, Gaudet M, Diver WR, Henderson BE, Haiman CA, Schumacher FR, Le Marchand L, Berg CD, Chanock SJ, ... ... Prentice RL, et al. Post-GWAS gene-environment interplay in breast cancer: results from the Breast and Prostate Cancer Cohort Consortium and a meta-analysis on 79,000 women. Human Molecular Genetics. 23: 5260-70. PMID 24895409 DOI: 10.1093/Hmg/Ddu223  0.376
2014 Zhao S, Chlebowski RT, Anderson GL, Kuller LH, Manson JE, Gass M, Patterson R, Rohan TE, Lane DS, Beresford SA, Lavasani S, Rossouw JE, Prentice RL. Sex hormone associations with breast cancer risk and the mediation of randomized trial postmenopausal hormone therapy effects. Breast Cancer Research : Bcr. 16: R30. PMID 24670297 DOI: 10.1186/Bcr3632  0.545
2014 Beasley JM, LaCroix AZ, Larson JC, Huang Y, Neuhouser ML, Tinker LF, Jackson R, Snetselaar L, Johnson KC, Eaton CB, Prentice RL. Biomarker-calibrated protein intake and bone health in the Women's Health Initiative clinical trials and observational study. The American Journal of Clinical Nutrition. 99: 934-40. PMID 24552750 DOI: 10.3945/Ajcn.113.076786  0.329
2014 Chen LS, Prentice RL, Wang P. A penalized EM algorithm incorporating missing data mechanism for Gaussian parameter estimation. Biometrics. 70: 312-22. PMID 24471933 DOI: 10.1111/Biom.12149  0.318
2014 Huang Y, Van Horn L, Tinker LF, Neuhouser ML, Carbone L, Mossavar-Rahmani Y, Thomas F, Prentice RL. Measurement error corrected sodium and potassium intake estimation using 24-hour urinary excretion. Hypertension. 63: 238-44. PMID 24277763 DOI: 10.1161/Hypertensionaha.113.02218  0.345
2014 Shufelt CL, Merz CN, Prentice RL, Pettinger MB, Rossouw JE, Aroda VR, Kaunitz AM, Lakshminarayan K, Martin LW, Phillips LS, Manson JE. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause (New York, N.Y.). 21: 260-6. PMID 24045672 DOI: 10.1097/Gme.0B013E31829A64F9  0.324
2014 Prentice RL, Jackson RD, Pettinger M, Rossouw JE. Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: Response to Neupane Osteoporosis International. 25: 1195. PMID 23912558 DOI: 10.1007/S00198-013-2461-Z  0.356
2014 Chlebowski RT, Anderson GL, Aragaki AK, Prentice RL, Demark-Wahnefried W. Menopausal hormone therapy and breast cancer by body mass index (BMI) and African ancestry. Journal of Clinical Oncology. 32: 1503-1503. DOI: 10.1200/Jco.2014.32.15_Suppl.1503  0.389
2014 Prentice RL. Self-consistent nonparametric maximum likelihood estimator of the bivariate survivor function Biometrika. 101: 505-518. DOI: 10.1093/Biomet/Asu010  0.347
2013 Prentice RL, Zhao S, Johnson M, Aragaki A, Hsia J, Jackson RD, Rossouw JE, Manson JE, Hanash SM. Proteomic risk markers for coronary heart disease and stroke: validation and mediation of randomized trial hormone therapy effects on these diseases. Genome Medicine. 5: 112. PMID 24373343 DOI: 10.1186/Gm517  0.519
2013 Beasley JM, Wertheim BC, LaCroix AZ, Prentice RL, Neuhouser ML, Tinker LF, Kritchevsky S, Shikany JM, Eaton C, Chen Z, Thomson CA. Biomarker-calibrated protein intake and physical function in the Women's Health Initiative. Journal of the American Geriatrics Society. 61: 1863-71. PMID 24219187 DOI: 10.1111/Jgs.12503  0.317
2013 Prentice RL, Manson JE, Anderson GL, LaCroix AZ, Shumaker SA, Chlebowski RT, Howard BV, Stefanick ML, Jackson RD, Wactawski-Wende J, Rossouw JE. Women's health initiative view of estrogen avoidance and all-cause mortality American Journal of Public Health. 103: e2. PMID 24134350 DOI: 10.2105/Ajph.2013.301604  0.336
2013 Prentice RL, Neuhouser ML, Tinker LF, Pettinger M, Thomson CA, Mossavar-Rahmani Y, Thomas F, Qi L, Huang Y. An exploratory study of respiratory quotient calibration and association with postmenopausal breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 2374-83. PMID 24108790 DOI: 10.1158/1055-9965.Epi-13-0511  0.606
2013 Manson JE, Chlebowski RT, Stefanick ML, Aragaki AK, Rossouw JE, Prentice RL, Anderson G, Howard BV, Thomson CA, LaCroix AZ, Wactawski-Wende J, Jackson RD, Limacher M, Margolis KL, Wassertheil-Smoller S, et al. Menopausal hormone therapy and health outcomes during the intervention and extended poststopping phases of the Women's Health Initiative randomized trials. Jama. 310: 1353-68. PMID 24084921 DOI: 10.1097/01.Ogx.0000444679.66386.38  0.412
2013 Prentice RL, Pettinger M, Tinker LF, Huang Y, Thomson CA, Johnson KC, Beasley J, Anderson G, Shikany JM, Chlebowski RT, Neuhouser ML. Regression calibration in nutritional epidemiology: example of fat density and total energy in relationship to postmenopausal breast cancer. American Journal of Epidemiology. 178: 1663-72. PMID 24064741 DOI: 10.1093/Aje/Kwt198  0.394
2013 Prentice RL, Tinker LF, Huang Y, Neuhouser ML. Calibration of self-reported dietary measures using biomarkers: an approach to enhancing nutritional epidemiology reliability. Current Atherosclerosis Reports. 15: 353. PMID 23881548 DOI: 10.1007/S11883-013-0353-5  0.374
2013 Mossavar-Rahmani Y, Tinker LF, Huang Y, Neuhouser ML, McCann SE, Seguin RA, Vitolins MZ, Curb JD, Prentice RL. Factors relating to eating style, social desirability, body image and eating meals at home increase the precision of calibration equations correcting self-report measures of diet using recovery biomarkers: findings from the Women's Health Initiative. Nutrition Journal. 12: 63. PMID 23679960 DOI: 10.1186/1475-2891-12-63  0.318
2013 Chlebowski RT, Manson JE, Anderson GL, Cauley JA, Aragaki AK, Stefanick ML, Lane DS, Johnson KC, Wactawski-Wende J, Chen C, Qi L, Yasmeen S, Newcomb PA, Prentice RL. Estrogen plus progestin and breast cancer incidence and mortality in the Women's Health Initiative Observational Study. Journal of the National Cancer Institute. 105: 526-35. PMID 23543779 DOI: 10.1093/Jnci/Djt043  0.581
2013 Neuhouser ML, Di C, Tinker LF, Thomson C, Sternfeld B, Mossavar-Rahmani Y, Stefanick ML, Sims S, Curb JD, Lamonte M, Seguin R, Johnson KC, Prentice RL. Physical activity assessment: biomarkers and self-report of activity-related energy expenditure in the WHI. American Journal of Epidemiology. 177: 576-85. PMID 23436896 DOI: 10.1093/Aje/Kws269  0.304
2013 Ladd JJ, Chao T, Johnson MM, Qiu J, Chin A, Israel R, Pitteri SJ, Mao J, Wu M, Amon LM, McIntosh M, Li C, Prentice R, Disis N, Hanash S. Autoantibody signatures involving glycolysis and splicesome proteins precede a diagnosis of breast cancer among postmenopausal women. Cancer Research. 73: 1502-13. PMID 23269276 DOI: 10.1158/0008-5472.Can-12-2560  0.319
2013 Prentice RL, Pettinger MB, Jackson RD, Wactawski-Wende J, Lacroix AZ, Anderson GL, Chlebowski RT, Manson JE, Van Horn L, Vitolins MZ, Datta M, Leblanc ES, Cauley JA, Rossouw JE. Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort study Osteoporosis International. 24: 567-580. PMID 23208074 DOI: 10.1007/S00198-012-2224-2  0.334
2013 Lavasani SM, Chlebowski RT, Prentice RL, Kato I, Wactawski-Wende J, Johnson K, Young A, Hubbell FA, Simon MS. Estrogen and colorectal cancer incidence and mortality in the Women's Health Initiative clinical trial. Journal of Clinical Oncology. 31: 3594-3594. DOI: 10.1200/Jco.2013.31.15_Suppl.3594  0.401
2013 Ladd J, Johnson M, Chao T, Chin A, Pitteri S, Mao J, Amon LM, McIntosh M, Lampe P, Li C, Prentice R, Disis N, Hanash S. Abstract 2491: Dynamics changes in antigen-autoantibody profiles involving glycolysis and spliceosome proteins precede a diagnosis of ER+ and triple negative breast cancer among post-menopausal women. Cancer Research. 73: 2491-2491. DOI: 10.1158/1538-7445.Am2013-2491  0.337
2012 Dai JY, Kooperberg C, Leblanc M, Prentice RL. Two-stage testing procedures with independent filtering for genome-wide gene-environment interaction. Biometrika. 99: 929-944. PMID 23843674 DOI: 10.1093/Biomet/Ass044  0.304
2012 Simon MS, Chlebowski RT, Wactawski-Wende J, Johnson KC, Muskovitz A, Kato I, Young A, Hubbell FA, Prentice RL. Estrogen plus progestin and colorectal cancer incidence and mortality. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 30: 3983-90. PMID 23008295 DOI: 10.1200/Jco.2012.42.7732  0.361
2012 Li CI, Mirus JE, Zhang Y, Ramirez AB, Ladd JJ, Prentice RL, McIntosh MW, Hanash SM, Lampe PD. Discovery and preliminary confirmation of novel early detection biomarkers for triple-negative breast cancer using preclinical plasma samples from the Women's Health Initiative observational study. Breast Cancer Research and Treatment. 135: 611-8. PMID 22903690 DOI: 10.1007/S10549-012-2204-4  0.345
2012 Lu H, Ladd J, Feng Z, Wu M, Goodell V, Pitteri SJ, Li CI, Prentice R, Hanash SM, Disis ML. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera. Cancer Prevention Research (Philadelphia, Pa.). 5: 1036-43. PMID 22715141 DOI: 10.1158/1940-6207.Capr-11-0558  0.326
2012 Huang Y, Ballinger DG, Dai JY, Peters U, Hinds DA, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, McTiernan A, Rohan T, Prentice RL. Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Medicine. 4: 19. PMID 22410340 DOI: 10.1186/Gm318  0.34
2012 Amon LM, Pitteri SJ, Li CI, McIntosh M, Ladd JJ, Disis M, Porter P, Wong CH, Zhang Q, Lampe P, Prentice RL, Hanash SM. Concordant release of glycolysis proteins into the plasma preceding a diagnosis of ER+ breast cancer. Cancer Research. 72: 1935-42. PMID 22367215 DOI: 10.1158/0008-5472.Can-11-3266  0.334
2012 Ladd JJ, Busald T, Johnson MM, Zhang Q, Pitteri SJ, Wang H, Brenner DE, Lampe PD, Kucherlapati R, Feng Z, Prentice RL, Hanash SM. Increased plasma levels of the APC-interacting protein MAPRE1, LRG1, and IGFBP2 preceding a diagnosis of colorectal cancer in women. Cancer Prevention Research (Philadelphia, Pa.). 5: 655-64. PMID 22277732 DOI: 10.1158/1940-6207.Capr-11-0412  0.321
2012 Shaw PA, Prentice RL. Hazard ratio estimation for biomarker-calibrated dietary exposures. Biometrics. 68: 397-407. PMID 22004367 DOI: 10.1111/J.1541-0420.2011.01690.X  0.513
2012 Lee P, Fu YP, Figueroa JD, Prokunina-Olsson L, Gonzalez-Bosquet J, Kraft P, Wang Z, Jacobs KB, Yeager M, Horner MJ, Hankinson SE, Hutchinson A, Chatterjee N, Garcia-Closas M, Ziegler RG, ... ... Prentice R, et al. Fine mapping of 14q24.1 breast cancer susceptibility locus. Human Genetics. 131: 479-90. PMID 21959381 DOI: 10.1007/S00439-011-1088-4  0.327
2012 Peters U, Hutter CM, Hsu L, Schumacher FR, Conti DV, Carlson CS, Edlund CK, Haile RW, Gallinger S, Zanke BW, Lemire M, Rangrej J, Vijayaraghavan R, Chan AT, Hazra A, ... ... Prentice RL, et al. Meta-analysis of new genome-wide association studies of colorectal cancer risk. Human Genetics. 131: 217-34. PMID 21761138 DOI: 10.1007/S00439-011-1055-0  0.321
2012 Chlebowski RT, Anderson GL, Kuller LH, Aragaki AK, Manson JE, Stefanick ML, Johnson K, Gass M, Lane DS, Ockene J, Sarto G, Wactawski-Wende J, Rajkovic A, Prentice RL. Estrogen plus progestin (E+P) and breast cancer incidence and mortality. Journal of Clinical Oncology. 30: 1501-1501. DOI: 10.1200/Jco.2012.30.15_Suppl.1501  0.364
2011 Prentice RL, Huang Y. Measurement error modeling and nutritional epidemiology association analyses. The Canadian Journal of Statistics = Revue Canadienne De Statistique. 39: 498-509. PMID 23606784 DOI: 10.1002/Cjs.10116  0.39
2011 Prentice R. Invited commentary on Pearl and principal stratification. The International Journal of Biostatistics. 7: 1-15. PMID 23093048 DOI: 10.2202/1557-4679.1359  0.332
2011 Tinker LF, Sarto GE, Howard BV, Huang Y, Neuhouser ML, Mossavar-Rahmani Y, Beasley JM, Margolis KL, Eaton CB, Phillips LS, Prentice RL. Biomarker-calibrated dietary energy and protein intake associations with diabetes risk among postmenopausal women from the Women's Health Initiative. The American Journal of Clinical Nutrition. 94: 1600-6. PMID 22071707 DOI: 10.3945/Ajcn.111.018648  0.347
2011 Prentice RL. Empirical evaluation of gene and environment interactions: methods and potential. Journal of the National Cancer Institute. 103: 1209-10. PMID 21791675 DOI: 10.1093/Jnci/Djr279  0.372
2011 Takata Y, Kristal AR, King IB, Song X, Diamond AM, Foster CB, Hutter CM, Hsu L, Duggan DJ, Langer RD, Petrovitch H, Shikany JM, Vaughan TL, Lampe JW, Prentice RL, et al. Serum selenium, genetic variation in selenoenzymes, and risk of colorectal cancer: primary analysis from the Women's Health Initiative Observational Study and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1822-30. PMID 21765007 DOI: 10.1158/1055-9965.Epi-11-0364  0.375
2011 Prentice RL, Mossavar-Rahmani Y, Huang Y, Van Horn L, Beresford SAA, Caan B, Tinker L, Schoeller D, Bingham S, Eaton CB, Thomson C, Johnson KC, Ockene J, Sarto G, Heiss G, et al. Evaluation and comparison of food records, recalls, and frequencies for energy and protein assessment by using recovery biomarkers American Journal of Epidemiology. 174: 591-603. PMID 21765003 DOI: 10.1093/Aje/Kwr140  0.305
2011 Huang Y, Ballinger DG, Dai JY, Peters U, Hinds DA, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, McTiernan A, Rohan T, Prentice RL. Genetic variants in the MRPS30 region and postmenopausal breast cancer risk. Genome Medicine. 3: 42. PMID 21702935 DOI: 10.1186/Gm258  0.359
2011 Beasley JM, Aragaki AK, LaCroix AZ, Neuhouser ML, Tinker LF, Cauley JA, Ensrud KE, Jackson RD, Prentice RL. Higher biomarker-calibrated protein intake is not associated with impaired renal function in postmenopausal women. The Journal of Nutrition. 141: 1502-7. PMID 21653574 DOI: 10.3945/Jn.110.135814  0.322
2011 Prentice RL. Biomarkers and the risk of stroke in the Women's Health Initiative. Women's Health (London, England). 7: 269-73. PMID 21612347 DOI: 10.2217/Whe.11.17  0.317
2011 Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Vitolins M, Kabat GC, Rohan TE, Li CI. Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 454-63. PMID 21364029 DOI: 10.1158/1055-9965.Epi-10-0974  0.348
2011 Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J, Kuller LH, Adams-Campbell LL, Lane D, Stefanick ML, Vitolins M, Kabat GC, Rohan TE, Li CI. Reproductive history and oral contraceptive use in relation to risk of triple-negative breast cancer. Journal of the National Cancer Institute. 103: 470-7. PMID 21346227 DOI: 10.1093/Jnci/Djr030  0.366
2011 Prentice RL, Huang Y, Kuller LH, Tinker LF, Horn LV, Stefanick ML, Sarto G, Ockene J, Johnson KC. Biomarker-calibrated energy and protein consumption and cardiovascular disease risk among postmenopausal women. Epidemiology (Cambridge, Mass.). 22: 170-9. PMID 21206366 DOI: 10.1097/Ede.0B013E31820839Bc  0.357
2011 Carty CL, Kooperberg C, Neuhouser ML, Tinker L, Howard B, Wactawski-Wende J, Beresford SA, Snetselaar L, Vitolins M, Allison M, Budrys N, Prentice R, Peters U. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. The American Journal of Clinical Nutrition. 93: 516-24. PMID 21177798 DOI: 10.3945/Ajcn.110.006395  0.372
2011 Prentice RL, Rossouw JE. "Preventing breast cancer in postmenopausal women by achievable diet modification: a missed opportunity in public health policy" (Dayal HH and Kalia A, The Breast 2010; 19: 309-311). Breast (Edinburgh, Scotland). 20: 99. PMID 21112212 DOI: 10.1016/J.Breast.2010.11.001  0.357
2011 Yang S, Prentice RL. Estimation of the 2-sample hazard ratio function using a semiparametric model. Biostatistics (Oxford, England). 12: 354-68. PMID 20860993 DOI: 10.1093/Biostatistics/Kxq061  0.365
2011 Prentice RL. Statistical Methods and Challenges in Epidemiology and Biomedical Research Essential Statistical Methods For Medical Statistics. 27: 1-26. DOI: 10.1016/B978-0-444-53737-9.50004-9  0.361
2010 Kocarnik JD, Hutter CM, Slattery ML, Berndt SI, Hsu L, Duggan DJ, Muehling J, Caan BJ, Beresford SA, Rajkovic A, Sarto GE, Marshall JR, Hammad N, Wallace RB, Makar KW, ... Prentice RL, et al. Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 3131-9. PMID 20978172 DOI: 10.1158/1055-9965.Epi-10-0878  0.303
2010 Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Sarto GE, Johnson KC, Wactawski-Wende J, Ravdin PM, Schenken R, Hendrix SL, ... ... Prentice RL, et al. Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. Jama. 304: 1684-92. PMID 20959578 DOI: 10.1001/Jama.2010.1500  0.4
2010 Pitteri SJ, Amon LM, Busald Buson T, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong CH, Zhang Q, Wang H, Lampe PD, Prentice RL, McIntosh MW, Hanash SM, Li CI. Detection of elevated plasma levels of epidermal growth factor receptor before breast cancer diagnosis among hormone therapy users. Cancer Research. 70: 8598-606. PMID 20959476 DOI: 10.1158/0008-5472.Can-10-1676  0.359
2010 Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA. Assessment of clinical validity of a breast cancer risk model combining genetic and clinical information. Journal of the National Cancer Institute. 102: 1618-27. PMID 20956782 DOI: 10.1093/Jnci/Djq388  0.374
2010 Li CI, Chlebowski RT, Freiberg M, Johnson KC, Kuller L, Lane D, Lessin L, O'Sullivan MJ, Wactawski-Wende J, Yasmeen S, Prentice R. Alcohol consumption and risk of postmenopausal breast cancer by subtype: the women's health initiative observational study. Journal of the National Cancer Institute. 102: 1422-31. PMID 20733117 DOI: 10.1093/Jnci/Djq316  0.349
2010 Huang Y, Hinds DA, Qi L, Prentice RL. Pooled versus individual genotyping in a breast cancer genome-wide association study. Genetic Epidemiology. 34: 603-12. PMID 20718042 DOI: 10.1002/Gepi.20517  0.541
2010 Prentice RL, Paczesny S, Aragaki A, Amon LM, Chen L, Pitteri SJ, McIntosh M, Wang P, Buson Busald T, Hsia J, Jackson RD, Rossouw JE, Manson JE, Johnson K, Eaton C, et al. Novel proteins associated with risk for coronary heart disease or stroke among postmenopausal women identified by in-depth plasma proteome profiling. Genome Medicine. 2: 48. PMID 20667078 DOI: 10.1186/Gm169  0.351
2010 Beasley JM, LaCroix AZ, Neuhouser ML, Huang Y, Tinker L, Woods N, Michael Y, Curb JD, Prentice RL. Protein intake and incident frailty in the Women's Health Initiative observational study. Journal of the American Geriatrics Society. 58: 1063-71. PMID 20487071 DOI: 10.1111/J.1532-5415.2010.02866.X  0.392
2010 Prentice RL. Dietary assessment and the reliability of nutritional epidemiology research reports. Journal of the National Cancer Institute. 102: 583-5. PMID 20407089 DOI: 10.1093/Jnci/Djq100  0.387
2010 Wacholder S, Hartge P, Prentice R, Garcia-Closas M, Feigelson HS, Diver WR, Thun MJ, Cox DG, Hankinson SE, Kraft P, Rosner B, Berg CD, Brinton LA, Lissowska J, Sherman ME, et al. Performance of common genetic variants in breast-cancer risk models. The New England Journal of Medicine. 362: 986-93. PMID 20237344 DOI: 10.1056/Nejmoa0907727  0.351
2010 Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, Michael Y, O'Sullivan MJ, Stefanick ML, Prentice R. Migraine history and breast cancer risk among postmenopausal women Journal of Clinical Oncology. 28: 1005-1010. PMID 20100960 DOI: 10.1200/Jco.2009.25.0423  0.412
2010 Prentice RL, Huang Y, Hinds DA, Peters U, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, Ballinger DG. Variation in the FGFR2 gene and the effect of a low-fat dietary pattern on invasive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 74-9. PMID 20056625 DOI: 10.1158/1055-9965.Epi-09-0663  0.383
2010 Zhong H, Prentice RL. Correcting "winner's curse" in odds ratios from genomewide association findings for major complex human diseases. Genetic Epidemiology. 34: 78-91. PMID 19639606 DOI: 10.1002/Gepi.20437  0.511
2010 Chlebowski RT, Anderson GL, Gass M, Lane DS, Aragaki AK, Kuller LH, Manson JE, Stefanick ML, Ockene J, Prentice RL. Breast cancer outcome and estrogen plus progestin use in postmenopausal women. Journal of Clinical Oncology. 28: 1507-1507. DOI: 10.1200/Jco.2010.28.15_Suppl.1507  0.398
2010 Prentice RL. Chronic disease prevention research methods and their reliability, with illustrations from the Women's Health Initiative Journal of the American Statistical Association. 105: 1431-1443. DOI: 10.1198/Jasa.2010.Tm10570  0.345
2010 Takata Y, King IB, Song X, Diamond AM, Foster CB, Hutter CM, Hsu L, Duggan DJ, Langer RD, Petrovitch H, Shikany JM, Vaughan TL, Kristal AR, Lampe JW, Prentice RL, et al. Abstract 4825: Serum selenium concentration and risk of colorectal cancer in postmenopausal women: The Women's Health Initiative Observational Study Cancer Research. 70: 4825-4825. DOI: 10.1158/1538-7445.Am10-4825  0.385
2010 Pitteri SJ, Amon LM, Buson TB, Zhang Y, Johnson MM, Chin A, Kennedy J, Wong C, Zhang Q, Wang H, Lampe PD, Prentice RL, McIntosh MW, Hanash SM, Li CI. Abstract 4815: Elevated plasma levels of epidermal growth factor receptor prior to diagnosis of breast cancer in preclinical specimens from the Women's Health Initiative Observational Study Cancer Research. 70: 4815-4815. DOI: 10.1158/1538-7445.Am10-4815  0.373
2010 Hutter CM, Chen LS, Liu Y, Slattery ML, Carlson CS, Vijayaraghavan R, Taverna D, Duggan D, Curtin K, Berndt SI, Schoen RE, Caan B, Jackson R, Kooperberg CL, LaCroix AZ, ... ... Prentice RL, et al. Abstract 4733: Gene-set analysis of colon cancer genome-wide association data: Identification of the TGF-beta pathway Cancer Research. 70: 4733-4733. DOI: 10.1158/1538-7445.Am10-4733  0.324
2010 Mealiffe ME, Stokowski RP, Rhees BK, Prentice RL, Pettinger M, Hinds DA. Clinical validity assessment of a breast cancer risk model combining genetic and clinical information Nature Precedings. DOI: 10.1038/Npre.2010.4295.1  0.334
2009 Pitteri SJ, Hanash SM, Aragaki A, Amon LM, Chen L, Busald Buson T, Paczesny S, Katayama H, Wang H, Johnson MM, Zhang Q, McIntosh M, Wang P, Kooperberg C, Rossouw JE, ... ... Prentice RL, et al. Postmenopausal estrogen and progestin effects on the serum proteome. Genome Medicine. 1: 121. PMID 20034393 DOI: 10.1186/Gm121  0.336
2009 Prentice RL, Huang Y, Hinds DA, Peters U, Pettinger M, Cox DR, Beilharz E, Chlebowski RT, Rossouw JE, Caan B, Ballinger DG. Variation in the FGFR2 gene and the effects of postmenopausal hormone therapy on invasive breast cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 3079-85. PMID 19861516 DOI: 10.1158/1055-9965.Epi-09-0611  0.364
2009 Prentice RL, Huang Y, Tinker LF, Beresford SA, Lampe JW, Neuhouser ML. Statistical Aspects of the Use of Biomarkers in Nutritional Epidemiology Research. Statistics in Biosciences. 1: 112-123. PMID 19841649 DOI: 10.1007/S12561-009-9003-4  0.347
2009 Prentice RL, Manson JE, Langer RD, Anderson GL, Pettinger M, Jackson RD, Johnson KC, Kuller LH, Lane DS, Wactawski-Wende J, Brzyski R, Allison M, Ockene J, Sarto G, Rossouw JE. Benefits and risks of postmenopausal hormone therapy when it is initiated soon after menopause. American Journal of Epidemiology. 170: 12-23. PMID 19468079 DOI: 10.1093/Aje/Kwp115  0.412
2009 Prentice RL, Pettinger M, Beresford SA, Wactawski-Wende J, Hubbell FA, Stefanick ML, Chlebowski RT. Colorectal cancer in relation to postmenopausal estrogen and estrogen plus progestin in the Women's Health Initiative clinical trial and observational study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 18: 1531-7. PMID 19423530 DOI: 10.1158/1055-9965.Epi-08-1209  0.389
2009 Katayama H, Paczesny S, Prentice R, Aragaki A, Faca VM, Pitteri SJ, Zhang Q, Wang H, Silva M, Kennedy J, Rossouw J, Jackson R, Hsia J, Chlebowski R, Manson J, et al. Application of serum proteomics to the Women's Health Initiative conjugated equine estrogens trial reveals a multitude of effects relevant to clinical findings. Genome Medicine. 1: 47. PMID 19402886 DOI: 10.1186/Gm47  0.356
2009 Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R, Morrison J, Maranian M, Pooley KA, Luben R, Eccles D, Evans DG, Fletcher O, Johnson N, dos Santos Silva I, ... ... Prentice R, et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2. Nature Genetics. 41: 585-90. PMID 19330027 DOI: 10.1038/Ng.354  0.323
2009 Prentice RL, Shaw PA, Bingham SA, Beresford SA, Caan B, Neuhouser ML, Patterson RE, Stefanick ML, Satterfield S, Thomson CA, Snetselaar L, Thomas A, Tinker LF. Biomarker-calibrated energy and protein consumption and increased cancer risk among postmenopausal women. American Journal of Epidemiology. 169: 977-89. PMID 19258487 DOI: 10.1093/Aje/Kwp008  0.561
2009 Prentice RL. Surrogate and mediating endpoints: current status and future directions. Journal of the National Cancer Institute. 101: 216-7. PMID 19211455 DOI: 10.1093/Jnci/Djn515  0.311
2009 Neuhouser ML, Wassertheil-Smoller S, Thomson C, Aragaki A, Anderson GL, Manson JE, Patterson RE, Rohan TE, van Horn L, Shikany JM, Thomas A, LaCroix A, Prentice RL. Multivitamin use and risk of cancer and cardiovascular disease in the Women's Health Initiative cohorts. Archives of Internal Medicine. 169: 294-304. PMID 19204221 DOI: 10.1001/Archinternmed.2008.540  0.393
2009 Chlebowski RT, Kuller LH, Prentice RL, Stefanick ML, Manson JE, Gass M, Aragaki AK, Ockene JK, Lane DS, Sarto GE, Rajkovic A, Schenken R, Hendrix SL, Ravdin PM, Rohan TE, et al. Breast cancer after use of estrogen plus progestin in postmenopausal women. The New England Journal of Medicine. 360: 573-87. PMID 19196674 DOI: 10.1056/Nejmoa0807684  0.383
2008 Li Y, Prentice RL, Lin X. Semiparametric Maximum Likelihood Estimation in Normal Transformation Models for Bivariate Survival Data. Biometrika. 95: 947-960. PMID 19079778 DOI: 10.1093/Biomet/Asn049  0.311
2008 Prentice RL. Data analysis methods and the reliability of analytic epidemiologic research. Epidemiology (Cambridge, Mass.). 19: 785-8; discussion 78. PMID 18813015 DOI: 10.1097/Ede.0B013E318188E83B  0.399
2008 Prentice RL. Women's health initiative studies of postmenopausal breast cancer. Advances in Experimental Medicine and Biology. 617: 151-60. PMID 18497039 DOI: 10.1007/978-0-387-69080-3_14  0.399
2008 Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Langer RD, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, O'Sullivan MJ, Rossouw JE, Anderson GL. Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study. American Journal of Epidemiology. 167: 1407-15. PMID 18448442 DOI: 10.1093/Aje/Kwn090  0.447
2008 Prentice RL, Chlebowski RT, Stefanick ML, Manson JE, Pettinger M, Hendrix SL, Hubbell FA, Kooperberg C, Kuller LH, Lane DS, McTiernan A, Jo O'Sullivan M, Rossouw JE, Anderson GL. Estrogen plus progestin therapy and breast cancer in recently postmenopausal women. American Journal of Epidemiology. 167: 1207-16. PMID 18372396 DOI: 10.1093/Aje/Kwn044  0.417
2008 Prentice RL, Anderson GL. The women's health initiative: lessons learned. Annual Review of Public Health. 29: 131-50. PMID 18348708 DOI: 10.1146/Annurev.Publhealth.29.020907.090947  0.394
2008 Neuhouser ML, Tinker L, Shaw PA, Schoeller D, Bingham SA, Horn LV, Beresford SA, Caan B, Thomson C, Satterfield S, Kuller L, Heiss G, Smit E, Sarto G, Ockene J, ... ... Prentice RL, et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology. 167: 1247-59. PMID 18344516 DOI: 10.1093/Aje/Kwn026  0.512
2008 Heiss G, Wallace R, Anderson GL, Aragaki A, Beresford SA, Brzyski R, Chlebowski RT, Gass M, LaCroix A, Manson JE, Prentice RL, Rossouw J, Stefanick ML. Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. Jama. 299: 1036-45. PMID 18319414 DOI: 10.1097/01.Ogx.0000318074.93077.Fa  0.348
2008 Zhong H, Prentice RL. Bias-reduced estimators and confidence intervals for odds ratios in genome-wide association studies. Biostatistics (Oxford, England). 9: 621-34. PMID 18310059 DOI: 10.1093/Biostatistics/Kxn001  0.483
2008 Pepe MS, Feng Z, Huang Y, Longton G, Prentice R, Thompson IM, Zheng Y. Integrating the predictiveness of a marker with its performance as a classifier. American Journal of Epidemiology. 167: 362-8. PMID 17982157 DOI: 10.1093/Aje/Kwm305  0.312
2008 Prentice RL, Thomson CA, Caan B, Chlebowski RT. Response: Re: Low-Fat Dietary Pattern and Cancer Incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial Jnci Journal of the National Cancer Institute. 100: 284-285. DOI: 10.1093/Jnci/Djm310  0.381
2007 Prentice RL. Observational studies, clinical trials, and the women's health initiative. Lifetime Data Analysis. 13: 449-62. PMID 17943443 DOI: 10.1007/S10985-007-9047-Z  0.395
2007 Prentice RL, Thomson CA, Caan B, Hubbell FA, Anderson GL, Beresford SA, Pettinger M, Lane DS, Lessin L, Yasmeen S, Singh B, Khandekar J, Shikany JM, Satterfield S, Chlebowski RT. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute. 99: 1534-43. PMID 17925539 DOI: 10.1093/Jnci/Djm159  0.404
2007 Prentice RL. Epidemiologic methods developments: a look forward to the year 2032. Annals of Epidemiology. 17: 906-10. PMID 17855116 DOI: 10.1016/J.Annepidem.2007.07.003  0.328
2007 Anderson GL, Kooperberg C, Geller N, Rossouw JE, Pettinger M, Prentice RL. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials. Clinical Trials (London, England). 4: 207-17. PMID 17715246 DOI: 10.1177/1740774507079252  0.353
2007 Sugar EA, Wang CY, Prentice RL. Logistic regression with exposure biomarkers and flexible measurement error. Biometrics. 63: 143-51. PMID 17447939 DOI: 10.1111/J.1541-0420.2006.00632.X  0.342
2007 Gorfine M, Lipshtat N, Freedman LS, Prentice RL. Linear measurement error models with restricted sampling. Biometrics. 63: 137-42. PMID 17447938 DOI: 10.1111/J.1541-0420.2006.00624.X  0.333
2007 Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, Lacroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause Journal of the American Medical Association. 297: 1465-1477. PMID 17405972 DOI: 10.1001/Jama.297.13.1465  0.361
2007 Prentice RL. Clinical trials and observational studies to assess the chronic disease benefits and risks of multivitamin-multimineral supplements American Journal of Clinical Nutrition. 85: 308S-313S. PMID 17209216 DOI: 10.1093/Ajcn/85.1.308S  0.377
2006 Prentice RL. Research opportunities and needs in the study of dietary modification and cancer risk reduction: The role of biomarkers Journal of Nutrition. 136: 2668S-2670S. PMID 16988143 DOI: 10.1093/Jn/136.10.2668S  0.337
2006 Cauley JA, McTiernan A, Rodabough RJ, LaCroix A, Bauer DC, Margolis KL, Paskett ED, Vitolins MZ, Furberg CD, Chlebowski RT, Alving B, Rossouw J, Pottern L, Prentice R, Anderson G, et al. Statin use and breast cancer: Prospective results from the women's health initiative Journal of the National Cancer Institute. 98: 700-707. PMID 16705124 DOI: 10.1093/Jnci/Djj188  0.386
2006 Freedman LS, Potischman N, Kipnis V, Midthune D, Schatzkin A, Thompson FE, Troiano RP, Prentice R, Patterson R, Carroll R, Subar AF. A comparison of two dietary instruments for evaluating the fat-breast cancer relationship. International Journal of Epidemiology. 35: 1011-21. PMID 16672309 DOI: 10.1093/Ije/Dyl085  0.327
2006 Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Cyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR. Venous thrombosis and conjugated equine estrogen in women without a uterus Archives of Internal Medicine. 166: 772-780. PMID 16606815 DOI: 10.1001/Archinte.166.7.772  0.38
2006 Prentice RL, Langer RD, Stefanick ML, Howard BV, Pettinger M, Anderson GL, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. Combined analysis of Women's Health Initiative observational and clinical trial data on postmenopausal hormone treatment and cardiovascular disease. American Journal of Epidemiology. 163: 589-99. PMID 16484450 DOI: 10.1093/Aje/Kwj079  0.382
2006 Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer. The New England Journal of Medicine. 354: 684-96. PMID 16481636 DOI: 10.1056/Nejmoa055222  0.309
2006 Hsia J, Langer RD, Manson JE, Kuller L, Johnson KC, Hendrix SL, Pettinger M, Heckbert SR, Greep N, Crawford S, Eaton CB, Kostis JB, Caralis P, Prentice R. Conjugated equine estrogens and coronary heart disease: The women's health initiative Archives of Internal Medicine. 166: 357-365. PMID 16476878 DOI: 10.1097/01.Ogx.0000219472.72978.7A  0.319
2006 Howard BV, Van Horn L, Hsia J, Manson JE, Stefanick ML, Wassertheil-Smoller S, Kuller LH, LaCroix AZ, Langer RD, Lasser NL, Lewis CE, Limacher MC, Margolis KL, Mysiw WJ, Ockene JK, ... ... Prentice RL, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Jama. 295: 655-66. PMID 16467234 DOI: 10.1001/Jama.295.6.655  0.365
2006 Beresford SA, Johnson KC, Ritenbaugh C, Lasser NL, Snetselaar LG, Black HR, Anderson GL, Assaf AR, Bassford T, Bowen D, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, ... ... Prentice RL, et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Jama. 295: 643-54. PMID 16467233 DOI: 10.1001/Jama.295.6.643  0.385
2006 Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, Paskett E, Phillips L, Robbins J, Rossouw JE, Sarto GE, et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. Jama. 295: 629-42. PMID 16467232 DOI: 10.1001/Jama.295.6.629  0.407
2006 Prentice RL, Qi L. Aspects of the design and analysis of high-dimensional SNP studies for disease risk estimation. Biostatistics (Oxford, England). 7: 339-54. PMID 16443924 DOI: 10.1093/Biostatistics/Kxj020  0.564
2006 Prentice RL, Caan B, Chlebowski RT, Patterson R, Kuller LH, Ockene JK, Margolis KL, Limacher MC, Manson JE, Parker LM, Paskett E, Phillips L, Robbins J, Rossouw JE, Sarto GE, et al. Low-Fat dietary pattern and risk of invasive breast cancer: The women's health initiative randomized controlled dietary modification trial Obstetrical and Gynecological Survey. 61: 454-456. DOI: 10.1097/01.Ogx.0000224658.90363.E7  0.415
2006 Beresford SAA, Johnson KC, Ritenbaugh C, Lasser NL, Snetsclaar LG, Black HR, Anderson GL, Assaf AR, Bassford T, Bowen D, Brunner RL, Brzyski RG, Caan B, Chlebowski RT, Gass M, ... ... Prentice RL, et al. Low-fat dietary pattern and risk of colorectal cancer: The women's health initiative randomized controlled dietary modification trial Obstetrical and Gynecological Survey. 61: 456-458. DOI: 10.1097/01.Ogx.0000224608.12217.52  0.415
2006 Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, et al. Calcium plus vitamin D supplementation and the risk of colorectal cancer: Commentary Obstetrical and Gynecological Survey. 61: 389-390. DOI: 10.1097/01.Ogx.0000219471.14737.4F  0.383
2006 Jackson RD, Lacroix AZ, Gass M, Wallace RB, Robbins J, Lewis CE, Bassford T, Beresford SAA, Black HR, Blanchette P, Bonds DE, Brunner RL, Brzyski RG, Caan B, Cauley JA, ... ... Prentice RL, et al. Calcium plus vitamin D supplementation and the risk of fractures: Commentary Obstetrical and Gynecological Survey. 61: 386-388. DOI: 10.1097/01.Ogx.0000219470.83259.8D  0.315
2005 Prentice RL, Pettinger M, Anderson GL. Statistical issues arising in the Women's Health Initiative. Biometrics. 61: 899-911; discussion . PMID 16401257 DOI: 10.1111/J.0006-341X.2005.454_1.X  0.361
2005 Prentice RL, Langer R, Stefanick ML, Howard BV, Pettinger M, Anderson G, Barad D, Curb JD, Kotchen J, Kuller L, Limacher M, Wactawski-Wende J. Combined postmenopausal hormone therapy and cardiovascular disease: Toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial American Journal of Epidemiology. 162: 404-414. PMID 16033876 DOI: 10.1093/Aje/Kwi223  0.403
2005 Stefanick ML, Prentice RL, Anderson G, Gass M, Manson JE, Hendrix SL, Vista-Deck D, McNeeley G. Reanalysis of the Women's Health Initiative oral contraceptive data reveals no evidence of delayed cardiovascular benefit. Fertility and Sterility. 83: 853-4. PMID 15820789 DOI: 10.1016/J.Fertnstert.2005.01.084  0.33
2005 Chlebowski RT, Chen Z, Anderson GL, Rohan T, Aragaki A, Lane D, Dolan NC, Paskett ED, McTiernan A, Hubbell FA, Adams-Campbell LL, Prentice R. Ethnicity and breast cancer: factors influencing differences in incidence and outcome. Journal of the National Cancer Institute. 97: 439-48. PMID 15770008 DOI: 10.1093/Jnci/Dji064  0.373
2005 Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M, Grimm RH, Howard BV, Assaf AR, Prentice R. Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: The Women's Health Initiative Observational Study Archives of Internal Medicine. 165: 500-508. PMID 15767524 DOI: 10.1001/Archinte.165.5.500  0.366
2005 Qi L, Wang CY, Prentice RL. Weighted estimators for proportional hazards regression with missing covariates Journal of the American Statistical Association. 100: 1250-1263. DOI: 10.1198/016214505000000295  0.543
2005 Yang S, Prentice R. Semiparametric analysis of short-term and long-term hazard ratios with two-sample survival data Biometrika. 92: 1-17. DOI: 10.1093/Biomet/92.1.1  0.306
2004 Chlebowski RT, Chen Z, Rohan T, Aragaki A, Lane D, Dolan N, Paskett E, Patterson R, Hubbell A, Prentice R. Ethnicity and breast cancer in the Women's Health Initiative: A unifying concept for unfavorable outcome in African American women. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 22: 1008. PMID 28014646 DOI: 10.1200/Jco.2004.22.14_Suppl.1008  0.37
2004 Anderson GL, Limacher M, Assaf AR, Bassford T, Beresford SA, Black H, Bonds D, Brunner R, Brzyski R, Caan B, Chlebowski R, Curb D, Gass M, Hays J, Heiss G, ... ... Prentice RL, et al. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. Jama. 291: 1701-12. PMID 15082697 DOI: 10.1001/Jama.291.14.1701  0.348
2004 Gorfine M, Hsu LI, Prentice RL. Nonparametric correction for covariate measurement error in a stratified Cox model Biostatistics. 5: 75-87. PMID 14744829 DOI: 10.1093/Biostatistics/5.1.75  0.307
2004 Prentice RL. Methodologic challenges in chronic disease population research. Biostatistics (Oxford, England). 2: 365-81. PMID 12933630 DOI: 10.1093/Biostatistics/2.4.365  0.333
2004 Prentice RL, Moodie FZ, Wu J. Hazard-based nonparametric survivor function estimation Journal of the Royal Statistical Society. Series B: Statistical Methodology. 66: 305-319. DOI: 10.1046/J.1369-7412.2003.05182.X  0.738
2003 Anderson GL, Manson J, Wallace R, Lund B, Hall D, Davis S, Shumaker S, Wang CY, Stein E, Prentice RL. Implementation of the Women's Health Initiative study design Annals of Epidemiology. 13: S5-S17. PMID 14575938 DOI: 10.1016/S1047-2797(03)00043-7  0.39
2003 Prentice RL, Kalbfleisch JD. Mixed discrete and continuous Cox regression model. Lifetime Data Analysis. 9: 195-210. PMID 12735496 DOI: 10.1023/A:1022935019768  0.346
2003 Gorfine M, Hsu L, Prentice RL. Estimation of dependence between paired correlated failure times in the presence of covariate measurement error Journal of the Royal Statistical Society. Series B: Statistical Methodology. 65: 643-661. DOI: 10.1111/1467-9868.00407  0.303
2002 Prentice RL, Sugar E, Wang CY, Neuhouser M, Patterson R. Research strategies and the use of nutrient biomarkers in studies of diet and chronic disease Public Health Nutrition. 5: 977-984. PMID 12633522 DOI: 10.1079/Phn2002382  0.405
2002 Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SAA, Howard BV, Johnson KC, Kotchen JM, Ockene J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal results from the women's health initiative randomized controlled trial Journal of the American Medical Association. 288: 321-333. PMID 12117397 DOI: 10.1001/Jama.288.3.321  0.437
2002 Hsu L, Prentice RL, Stanford JL. Some further results on incorporating risk factor information in assessing the dependence between paired failure times arising from case-control family studies: An application to prostate cancer Statistics in Medicine. 21: 863-876. PMID 11870822 DOI: 10.1002/Sim.1055  0.321
2001 De Gruttola VG, Clax P, DeMets DL, Downing GJ, Ellenberg SS, Friedman L, Gail MH, Prentice R, Wittes J, Zeger SL. Considerations in the evaluation of surrogate endpoints in clinical trials: Summary of a National Institutes of Health Workshop Controlled Clinical Trials. 22: 485-502. PMID 11578783 DOI: 10.1016/S0197-2456(01)00153-2  0.302
2001 Horner NK, Lampe JW, Patterson RE, Neuhouser ML, Beresford SA, Prentice RL. Indirect calorimetry protocol development for measuring resting metabolic rate as a component of total energy expenditure in free-living postmenopausal women. The Journal of Nutrition. 131: 2215-8. PMID 11481420 DOI: 10.1093/Jn/131.8.2215  0.309
2001 Xie SX, Wang CY, Prentice RL. A risk set calibration method for failure time regression by using a covariate reliability sample Journal of the Royal Statistical Society. Series B: Statistical Methodology. 63: 855-870. DOI: 10.1111/1467-9868.00317  0.352
2000 Prentice RL. Future possibilities in the prevention of breast cancer. Fat and fiber and breast cancer research Breast Cancer Research. 2: 268-276. PMID 11250720 DOI: 10.1186/Bcr68  0.36
2000 Fan J, Hsu L, Prentice RL. Dependence Estimation over a Finite Bivariate Failure Time Region Lifetime Data Analysis. 6: 343-355. PMID 11190604 DOI: 10.1023/A:1026557315306  0.305
2000 Fan J, Prentice RL, Hsu L. A class of weighted dependence measures for bivariate failure time data Journal of the Royal Statistical Society. Series B: Statistical Methodology. 62: 181-190. DOI: 10.1111/1467-9868.00227  0.322
1999 Wang CY, Anderson GL, Prentice RL. Estimation of the correlation between nutrient intake measures under restricted sampling Biometrics. 55: 711-717. PMID 11314997 DOI: 10.1111/J.0006-341X.1999.00711.X  0.376
1999 Andersen GL, Prentice RL. Individually randomized intervention trials for disease prevention and control Statistical Methods in Medical Research. 8: 287-309. PMID 10730335 DOI: 10.1177/096228029900800403  0.325
1999 Prentice RL. On non-parametric maximum likelihood estimation of the bivariate survivor function Statistics in Medicine. 18: 2517-2527. PMID 10474157 DOI: 10.1002/(Sici)1097-0258(19990915/30)18:17/18<2517::Aid-Sim273>3.0.Co;2-F  0.309
1999 Satia JA, Patterson RE, Herrero R, Jin F, Dai Q, King IB, Chen C, Kristal AR, Prentice RL, Rossing MA. Study of diet, biomarkers and cancer risk in the United States, China and Costa Rica International Journal of Cancer. 82: 28-32. PMID 10360816 DOI: 10.1002/(Sici)1097-0215(19990702)82:1<28::Aid-Ijc6>3.0.Co;2-X  0.313
1999 Hsu LI, Prentice RL, Zhao LP, Fan JJ. On dependence estimation using correlated failure time data from case-control family studies Biometrika. 86: 743-753. DOI: 10.1093/Biomet/86.4.743  0.334
1999 Yang S, Prentice RL. Semiparametric Inference in the Proportional Odds Regression Model Journal of the American Statistical Association. 94: 125-136. DOI: 10.1080/01621459.1999.10473829  0.337
1998 Anderson AB, Prentice RL. On the accommodation of disease rate correlations in aggregate data studies of disease risk factors. Biometrics. 54: 1527-40. PMID 9883550 DOI: 10.2307/2533677  0.319
1998 Anderson G, Cummings S, Freedman LS, Furberg C, Henderson M, Johnson SR, Kuller L, Manson J, Oberman A, Prentice RL, Rossouw. JE, Finnegan L, Hiatt R, Pottern L, McGowan J, et al. Design of the Women's Health Initiative clinical trial and observational study Controlled Clinical Trials. 19: 61-109. PMID 9492970 DOI: 10.1016/S0197-2456(97)00078-0  0.374
1998 Zhao LP, Hsu LI, Holte S, Chen Y, Quiaoit F, Prentice RL. Combined association and aggregation analysis of data from case-control family studies Biometrika. 85: 299-315. DOI: 10.1093/Biomet/85.2.299  0.306
1997 Cai J, Prentice RL. Regression Estimation Using Multivariate Failure Time Data and a Common Baseline Hazard Function Model Lifetime Data Analysis. 3: 197-213. PMID 9384652 DOI: 10.1023/A:1009613313677  0.501
1997 Wang CY, Hsu L, Feng ZD, Prentice RL. Regression calibration in failure time regression Biometrics. 53: 131-145. PMID 9147589 DOI: 10.2307/2533103  0.326
1997 Prentice RL. Breast mammographic changes among women adopting a low-fat eating pattern Journal of the National Cancer Institute. 89: 466-467. PMID 9085999 DOI: 10.1093/Jnci/89.7.466  0.321
1997 Prentice RL, Hsu LI. Regression on hazard ratios and cross ratios in multivariate failure time analysis Biometrika. 84: 349-363. DOI: 10.1093/Biomet/84.2.349  0.331
1996 Bowen D, Clifford CK, Coates R, Evans M, Feng Z, Fouad M, George V, Gerace T, Grizzle JE, Hall WD, Hearn M, Henderson M, Kestin M, Kristal A, Leary ET, ... ... Prentice R, et al. The Women's Health Trial Feasibility Study in Minority Populations: design and baseline descriptions. Annals of Epidemiology. 6: 507-19. PMID 8978881 DOI: 10.1016/S1047-2797(96)00072-5  0.343
1996 Freedman L, Anderson G, Kipnis V, Prentice R, Wang CY, Rossouw J, Wittes J, DeMets D. Approaches to monitoring the results of long-term disease prevention trials: Examples from the Women's Health Initiative Controlled Clinical Trials. 17: 509-525. PMID 8974210 DOI: 10.1016/S0197-2456(96)00016-5  0.327
1996 Prentice RL. Measurement error and results from analytic epidemiology: dietary fat and breast cancer. Journal of the National Cancer Institute. 88: 1738-47. PMID 8944004 DOI: 10.1093/Jnci/88.23.1738  0.368
1996 Sheppard L, Prentice RL, Rossing MA. Design considerations for estimation of exposure effects on disease risk, using aggregate data studies Statistics in Medicine. 15: 1849-1858. PMID 8888477 DOI: 10.1002/(Sici)1097-0258(19960915)15:17<1849::Aid-Sim396>3.0.Co;2-4  0.321
1996 Prentice RL. Design issues in cohort studies. Statistical Methods in Medical Research. 4: 273-92. PMID 8745127 DOI: 10.1177/096228029500400402  0.313
1996 Prentice RL, Rossouw JE, Johnson SR, Freedman LS, McTiernan A. The Role of Randomized Controlled Trials in Assessing the Benefits and Risks of Long-Term Hormone Replacement Therapy: Example of the Womenʼs Health Initiative Menopause. 3: 71-76. DOI: 10.1097/00042192-199603020-00003  0.311
1996 Hsu L, Prentice RL. On assessing the strength of dependency between failure time variates Biometrika. 83: 491-506. DOI: 10.1093/Biomet/83.3.491  0.327
1995 Prentice RL. Dietary fat reduction as a hypothesis for the prevention of postmenopausal breast cancer, and a discussion of hypothesis testing research strategies. Advances in Experimental Medicine and Biology. 364: 25-33. PMID 7725957 DOI: 10.1007/978-1-4615-2510-3_3  0.406
1995 Prentice RL. On the role, design, and analysis of disease prevention trials. Controlled Clinical Trials. 16: 249-58. PMID 7587213 DOI: 10.1016/S0197-2456(95)80010-7  0.302
1995 Sheppard L, Prentice RL. On the reliability and precision of within- and between- population estimates of relative rate parameters. Biometrics. 51: 853-863. DOI: 10.2307/2532987  0.33
1995 CAI J, PRENTICE RL. Estimating equations for hazard ratio parameters based on correlated failure time data Biometrika. 82: 151-164. DOI: 10.1093/Biomet/82.1.151  0.478
1995 Prentice RL, Sheppard L. Aggregate data studies of disease risk factors Biometrika. 82: 113-125. DOI: 10.1093/Biomet/82.1.113  0.384
1994 Prentice R, Henderson M, Furberg C, Kuller L. Women's health and diet [1] Nature. 367: 404. PMID 8107792 DOI: 10.1038/367404A0  0.315
1994 Fleming TR, Prentice RL, Pepe MS, Glidden D. Surrogate and auxiliary endpoints in clinical trials, with potential applications in cancer and AIDS research Statistics in Medicine. 13: 955-968. PMID 8047747 DOI: 10.1002/Sim.4780130906  0.324
1993 Prentice RL. Breast cancer risk from diet, tobacco, and alcohol. Jama. 269: 1790-1; author reply. PMID 8459505 DOI: 10.1001/Jama.1993.03500140042026  0.422
1993 Prentice RL, Cai J. Amendments and Corrections: Covariance and Survivor Function Estimation Using Censored Multivariate Failure Time Data Biometrika. 80: 711. DOI: 10.2307/2337193  0.426
1993 Freedman LS, Prentice RL, Clifford C, Harlan W, Henderson M, Rossouw J. Dietary fat and breast cancer Journal of the National Cancer Institute. 85: 764-765. DOI: 10.1093/Jnci/85.10.764  0.342
1992 PRENTICE RL, CAI J. Covariance and survivor function estimation using censored multivariate failure time data Biometrika. 79: 495-512. DOI: 10.1093/Biomet/79.3.495  0.488
1991 Prentice RL. Aspects of the science of cancer prevention trials: lessons from the conduct and planning of clinical trials of a low-fat diet intervention among women. Preventive Medicine. 20: 147-57. PMID 2008423 DOI: 10.1016/0091-7435(91)90015-V  0.353
1991 Prentice RL. Epidemiologic data on exogenous hormones and hepatocellular carcinoma and selected other cancers. Preventive Medicine. 20: 38-46. PMID 1848935 DOI: 10.1016/0091-7435(91)90005-O  0.307
1990 Prentice RL. Opportunities for enhancing efficiency and reducing cost in large scale disease prevention trials: a statistical perspective. Statistics in Medicine. 9: 161-70; discussion 1. PMID 2345832 DOI: 10.1002/Sim.4780090123  0.331
1990 Prentice R, Thompson D, Clifford C, Gorbach S, Goldin B, Byar D. Dietary fat reduction and plasma estradiol concentration in healthy postmenopausal women. The Women's Health Trial Study Group. Journal of the National Cancer Institute. 82: 129-34. PMID 2294222 DOI: 10.1093/Jnci/82.2.129  0.349
1990 Prentice RL, Sheppard L. Dietary fat and cancer: consistency of the epidemiologic data, and disease prevention that may follow from a practical reduction in fat consumption. Cancer Causes & Control. 1: 81-97. PMID 2102280 DOI: 10.1007/Bf00053187  0.408
1989 Pepe MS, Self SG, Prentice RL. Further results on covariate measurement errors in cohort studies with time to response data Statistics in Medicine. 8: 1167-1178. PMID 2799136 DOI: 10.1002/Sim.4780080918  0.349
1989 Prentice RL, Sheppard L. Validity of international, time trend, and migrant studies of dietary factors and disease risk. Preventive Medicine. 18: 167-79. PMID 2787026 DOI: 10.1016/0091-7435(89)90064-9  0.368
1989 Prentice RL. Surrogate endpoints in clinical trials: definition and operational criteria. Statistics in Medicine. 8: 431-40. PMID 2727467 DOI: 10.1002/Sim.4780080407  0.304
1988 Self S, Prentice R, Iverson D, Henderson M, Thompson D, Byar D, Insull W, Gorbach SL, Clifford C, Goldman S. Statistical design of the Women's Health Trial. Controlled Clinical Trials. 9: 119-36. PMID 3396363 DOI: 10.1016/0197-2456(88)90033-5  0.428
1988 Prentice RL, Self SG. Aspects of the use of relative risk models in the design and analysis of cohort studies and prevention trials Statistics in Medicine. 7: 275-287. PMID 3353608 DOI: 10.1002/Sim.4780070127  0.361
1988 Prentice RL, Kakar F, Hursting S, Sheppard L, Klein R, Kushi LH. Aspects of the rationale for the Women's Health Trial. Journal of the National Cancer Institute. 80: 802-14. PMID 3292773 DOI: 10.1093/Jnci/80.11.802  0.426
1987 Prentice RL, Thomas DB. On the epidemiology of oral contraceptives and disease Advances in Cancer Research. 49: 285-401. PMID 3314396 DOI: 10.1016/S0065-230X(08)60801-5  0.369
1986 Prentice RL, Moolgavkar SH, Farewell VT. Biostatistical issues and concepts in epidemiologic research Journal of Chronic Diseases. 39: 1169-1183. PMID 3793846 DOI: 10.1016/0021-9681(86)90147-5  0.322
1986 Prentice RL, Mason MW. On the application of linear relative risk regression models. Biometrics. 42: 109-120. DOI: 10.2307/2531247  0.315
1986 PRENTICE RL. A case-cohort design for epidemiologic cohort studies and disease prevention trials Biometrika. 73: 1-11. DOI: 10.1093/Biomet/73.1.1  0.362
1985 Prentice RL. Relative risk regression analysis of epidemiologic data. Environmental Health Perspectives. 63: 225-234. PMID 4076087 DOI: 10.1289/Ehp.8563225  0.302
1984 Prentice RL, Vollmer WM, Kalbfleisch JD. On the use of case series to identify disease risk factors. Biometrics. 40: 445-458. DOI: 10.2307/2531397  0.301
1983 Prentice RL, Self SG. Asymptotic Distribution Theory for Cox-Type Regression Models with General Relative Risk Form The Annals of Statistics. 11: 804-813. DOI: 10.1214/Aos/1176346247  0.301
1981 Smith DC, Prentice RL, Bauermeister DE. Endometrial carcinoma: histopathology, survival, and exogenous estrogens. Gynecologic and Obstetric Investigation. 12: 169-79. PMID 7250780 DOI: 10.1159/000299600  0.337
1981 Kalbfleisch JD, Prentice RL. Estimation of the average hazard ratio Biometrika. 68: 105-112. DOI: 10.1093/Biomet/68.1.105  0.315
1980 Deeg H, Storb R, Prentice R, Fritz T, Weiden P, Sale G, Graham T, Thomas E. Increased cancer risk in canine radiation chimeras Blood. 55: 233-239. DOI: 10.1182/Blood.V55.2.233.Bloodjournal552233  0.31
1979 Prentice RL, Kalbfleisch JD. Hazard rate models with covariates. Biometrics. 35: 25-39. DOI: 10.2307/2529934  0.324
1979 PRENTICE RL, PYKE R. Logistic disease incidence models and case-control studies Biometrika. 66: 403-411. DOI: 10.1093/Biomet/66.3.403  0.323
1978 Prentice RL, Kalbfleisch JD, Peterson AV, Flournoy N, Farewell VT, Breslow NE. The analysis of failure times in the presence of competing risks. Biometrics. 34: 541-554. DOI: 10.2307/2530374  0.308
1978 Prentice RL, Gloeckler LA. Regression analysis of grouped survival data with application to breast cancer data Biometrics. 34: 57-67. DOI: 10.2307/2529588  0.384
1978 Prentice RL. Linear rank tests with right censored data Biometrika. 65: 167-179. DOI: 10.1093/Biomet/65.1.167  0.304
1976 Prentice R. Use of the logistic model in retrospective studies. Biometrics. 32: 599-606. DOI: 10.2307/2529748  0.335
1975 Smith DC, Prentice R, Thompson DJ, Herrmann WL. Association of exogenous estrogen and endometrial carcinoma. The New England Journal of Medicine. 293: 1164-1167. PMID 1186789 DOI: 10.1056/Nejm197512042932302  0.352
Show low-probability matches.